CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2022		412,385
Beginning balance at Dec. 31, 2022	$ 1,040,609	$ 4,124	$ 2,106,886	$ (1,064,230)	$ (5,560)	$ (611)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(32,319)			(32,163)		(156)
Other comprehensive income (loss)	(670)				(670)
Exercise of stock options (in shares)		2,691
Exercise of stock options	13,268	$ 27	13,241
Vesting of restricted stock units (in shares)		584
Vesting of restricted stock units	0	$ 6	(6)
Shares withheld related to net share settlement (in shares)		(65)
Shares withheld related to net share settlement	(1,806)	$ (1)	(1,805)
Common stock repurchase (in shares)		(9,615)
Common stock repurchase	(201,462)	$ (96)	(201,366)
Stock-based compensation expense	53,980		53,980
Ending balance, (in shares) at Sep. 30, 2023		405,980
Ending balance at Sep. 30, 2023	871,600	$ 4,060	1,970,930	(1,096,393)	(6,230)	(767)
Beginning balance (in shares) at Jun. 30, 2023		405,427
Beginning balance at Jun. 30, 2023	879,446	$ 4,054	1,947,438	(1,064,957)	(6,369)	(720)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(31,483)			(31,436)		(47)
Other comprehensive income (loss)	139				139
Exercise of stock options (in shares)		424
Exercise of stock options	2,723	$ 5	2,718
Vesting of restricted stock units (in shares)		132
Vesting of restricted stock units	0	$ 1	(1)
Shares withheld related to net share settlement (in shares)		(3)
Shares withheld related to net share settlement	(63)		(63)
Common stock repurchase	102		102
Stock-based compensation expense	20,736		20,736
Ending balance, (in shares) at Sep. 30, 2023		405,980
Ending balance at Sep. 30, 2023	$ 871,600	$ 4,060	1,970,930	(1,096,393)	(6,230)	(767)
Beginning balance (in shares) at Dec. 31, 2023	406,387	406,387
Beginning balance at Dec. 31, 2023	$ 661,021	$ 4,064	1,986,899	(1,326,826)	(2,298)	(818)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(154,311)			(154,361)		50
Other comprehensive income (loss)	2,599				2,599
Exercise of stock options (in shares)		1,508
Exercise of stock options	2,758	$ 15	2,743
Vesting of restricted stock units (in shares)		2,409
Vesting of restricted stock units	0	$ 24	(24)
Shares withheld related to net share settlement (in shares)		(318)
Shares withheld related to net share settlement	(1,568)	$ (3)	(1,565)
Issuance of common stock (in shares)		1,974
Issuance of common stock	15,230	$ 20	15,210
Stock-based compensation expense	48,375		48,375
Dissolution of partially owned entity	$ 768					768
Ending balance, (in shares) at Sep. 30, 2024	411,960	411,960
Ending balance at Sep. 30, 2024	$ 574,872	$ 4,120	2,051,638	(1,481,187)	301	0
Beginning balance (in shares) at Jun. 30, 2024		411,447
Beginning balance at Jun. 30, 2024	675,867	$ 4,114	2,038,540	(1,363,572)	(2,447)	(768)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(117,615)			(117,615)		0
Other comprehensive income (loss)	2,748				2,748
Exercise of stock options (in shares)		32
Exercise of stock options	132	$ 0	132
Vesting of restricted stock units (in shares)		549
Vesting of restricted stock units	0	$ 7	(7)
Shares withheld related to net share settlement (in shares)		(68)
Shares withheld related to net share settlement	(287)	$ (1)	(286)
Stock-based compensation expense	13,259		13,259
Dissolution of partially owned entity	$ 768					768
Ending balance, (in shares) at Sep. 30, 2024	411,960	411,960
Ending balance at Sep. 30, 2024	$ 574,872	$ 4,120	$ 2,051,638	$ (1,481,187)	$ 301	$ 0